40 Participants Needed

HyperSight Imaging for Cancer

SD
Overseen BySean Davidson
Age: 18+
Sex: Any
Trial Phase: Academic
Sponsor: Varian, a Siemens Healthineers Company
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)

Trial Summary

Do I need to stop my current medications for the HyperSight Imaging trial?

The trial information does not specify whether you need to stop taking your current medications. It's best to discuss this with the trial coordinators or your doctor.

What data supports the effectiveness of the treatment HyperSight Imaging for cancer?

The research shows that HyperSight Imaging, a type of cone beam computed tomography (CBCT), provides high-quality images quickly, which can be useful in guiding cancer treatments. This technology is also being used in other medical procedures due to its ability to offer detailed images, suggesting it could be effective in cancer treatment as well.12345

Is HyperSight Imaging generally safe for humans?

Research on similar imaging technology, cone beam computed tomography (CBCT), shows that while it is useful, there are concerns about radiation exposure. Studies highlight the importance of understanding and managing radiation doses to ensure patient safety.678910

How is the HyperSight Imaging treatment different from other cancer treatments?

HyperSight Imaging uses a novel cone beam computed tomography (CBCT) platform that provides rapid and high-quality imaging, which can enhance the precision of cancer treatments by allowing better visualization and targeting of tumors compared to traditional imaging methods.1231112

What is the purpose of this trial?

The primary objective of radiation therapy is to deliver a therapeutic dose of radiation precisely to the target while minimizing exposure to healthy surrounding tissues. Image-guided radiation therapy (IGRT) involves acquiring cone beam computed tomography (CBCT) scans just before or during treatment sessions. By comparing the CBCT images with the reference images from the treatment planning process, clinicians can make necessary adjustments to ensure precise targeting and account for any changes that may have occurred since the initial planning. Conventional CBCT technology is, however, limited by several factors including long acquisition times that result in motion artifacts in the image, smaller fields of view that limit the volume of anatomy that can be imaged, poor image quality that limits soft tissue visibility, and artifacts created by dense metal implants. This study will evaluate a novel CBCT imaging solution ("HyperSight") that has the potential to address the challenges of conventional CBCT.

Eligibility Criteria

This trial is for individuals with various cancers (pelvic, head and neck, breast, lung, gastric, gastrointestinal tumors) who require precise radiation therapy. Participants should need image-guided radiation treatment but are not specified by other inclusion or exclusion criteria in the provided information.

Inclusion Criteria

Patient is willing and able to provide written consent.
I have a confirmed cancer diagnosis and need radiation therapy in specific areas.
I am able to get out of my bed or chair and move around.
See 1 more

Exclusion Criteria

I am getting a short course of radiation therapy for symptom relief.
I have a genetic condition that makes me sensitive to radiation.
Patient is part of a vulnerable population (per ISO 14155:2020, "individuals who are unable to fully understand all aspects of the investigation that are relevant to the decision to participate, or who could be manipulated or unduly influenced as a result of a compromised position, expectation of benefits or fear of retaliatory response"). This includes prisoners.
See 2 more

Timeline

Screening

Participants are screened for eligibility to participate in the trial

2-4 weeks

Imaging Evaluation

Subjects are imaged with the new HyperSight CBCT imaging system to evaluate image quality, noise, and artifact levels compared to conventional CT imaging.

1-9 weeks
Multiple imaging sessions

Follow-up

Participants are monitored for safety and effectiveness of the HyperSight imaging system, including patient experience and breath hold tolerance.

1 year

Treatment Details

Interventions

  • HyperSight Imaging
Trial Overview The study is testing 'HyperSight Imaging,' a new type of imaging technology designed to improve the accuracy of radiation therapy. It aims to overcome limitations like long scan times and poor image quality seen with conventional cone beam computed tomography (CBCT).
Participant Groups
1Treatment groups
Experimental Treatment
Group I: HyperSight Imaging armExperimental Treatment1 Intervention
Subjects are imaged with the new HyperSight CBCT imaging system.

Find a Clinic Near You

Who Is Running the Clinical Trial?

Varian, a Siemens Healthineers Company

Lead Sponsor

Trials
35
Recruited
7,200+

Findings from Research

The HyperSight cone beam computed tomography (CBCT) system significantly reduces image artifacts compared to the standard TrueBeam system, providing image quality comparable to fan beam CT (CTsim) in just 6 seconds of acquisition time.
HyperSight breath hold imaging (HSBH) offers improved image uniformity and a contrast-to-noise ratio over free breathing imaging, making it a valuable tool for accurate dose calculations in adaptive radiation therapy workflows.
Novel Technology Allowing Cone Beam Computed Tomography in 6 Seconds: A Patient Study of Comparative Image Quality.Robar, JL., Cherpak, A., MacDonald, RL., et al.[2023]
The multi-turn reverse helical scan significantly increased the longitudinal field of view in intraoperative CBCT imaging from 17 cm to 80 cm, enhancing the visualization of long anatomical sites during procedures.
This new imaging technique demonstrated high geometric accuracy (0.2 mm and 0.2 degrees) and excellent observer reliability (intraclass correlation coefficient above 0.900), making it a promising tool for assessing surgical interventions like pedicle screw placements.
Extended Intraoperative Longitudinal 3-Dimensional Cone Beam Computed Tomography Imaging With a Continuous Multi-Turn Reverse Helical Scan.Reynolds, T., Ma, YQ., Kanawati, AJ., et al.[2023]
C-arm Cone Beam CT (CBCT) enhances the safety and accuracy of interventional procedures by providing detailed cross-sectional imaging for preprocedural planning, intraprocedural guidance, and postprocedural assessment.
Despite some technical limitations, such as lower image quality compared to conventional CT and challenges in quantifying radiation doses, CBCT is proving to be a valuable tool in the interventional suite, with the potential for further evolution and integration into clinical practice.
C-arm Cone Beam Computed Tomography: A New Tool in the Interventional Suite.Raj, S., Irani, FG., Tay, KH., et al.[2020]

References

Novel Technology Allowing Cone Beam Computed Tomography in 6 Seconds: A Patient Study of Comparative Image Quality. [2023]
Extended Intraoperative Longitudinal 3-Dimensional Cone Beam Computed Tomography Imaging With a Continuous Multi-Turn Reverse Helical Scan. [2023]
C-arm Cone Beam Computed Tomography: A New Tool in the Interventional Suite. [2020]
Comparison of cone-beam imaging with orthopantomography and computerized tomography for assessment in presurgical implant dentistry. [2022]
Dental students' knowledge and attitude towards cone-beam computed tomography: An Indian scenario. [2018]
Radiation dose in cone beam CT guided ERCP. [2021]
Radiation exposure of abdominal cone beam computed tomography. [2015]
Evaluation of the accuracy of cone beam computerized tomography (CBCT): medical imaging technology in head and neck reconstruction. [2022]
CBCT in orthodontics: a systematic review on justification of CBCT in a paediatric population prior to orthodontic treatment. [2020]
10.United Statespubmed.ncbi.nlm.nih.gov
Megavoltage cone beam CT near surface dose measurements: potential implications for breast radiotherapy. [2017]
C-arm cone-beam computed tomography in interventional oncology: technical aspects and clinical applications. [2021]
12.United Statespubmed.ncbi.nlm.nih.gov
How I do it: Cone-beam CT during transarterial chemoembolization for liver cancer. [2018]
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top
Terms of Service·Privacy Policy·Cookies·Security